General Archive

Home » Archives for Hannah Rider
  • News releases

    New partnership aims to develop clinical tools for motor neuron disease prognosis, monitoring, and drug development

    LifeArc and ALS Therapy Development Institute (ALS TDI) have joined forces to identify, validate, and develop new biomarkers that are…

    Read more

  • News releases

    LifeArc and Kings College London team up to accelerate MND treatment development by driving systematic target validation

    LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London (KCL) to validate a…

    Read more

  • News releases

    LifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR)

    LifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR), which was published today, highlighting the desperate need…

    Read more

  • A busy hall of conference delegates networking and connecting with one another.
    Articles & blogs

    LifeArc Translational Science Summit: Highlights and key takeaways 

    The first ever LifeArc Translational Science Summit was a resounding success! Held on 23 April in London, the event brought…

    Read more

  • A female LifeArc scientist loads a plate into a lab machine
    News releases

    First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases

    Great Ormond Street Hospital (GOSH), supported by LifeArc and Great Ormond Street Hospital Children’s Charity (GOSH Charity), is announcing its…

    Read more

  • A collage of 8 Crick Africa Network Fellows
    News releases

    LifeArc supports 8 new fellows through Crick Africa Network (CAN) partnership

    The Crick Africa Network (CAN), a partnership between LifeArc, the Francis Crick Institute and 5 African institutions, has now awarded…

    Read more

  • News releases

    LifeArc signs statement calling for the UK to lead the G7 on R&D investment

    The Campaign for Science and Engineering (CaSE) has released a joint statement urging all political parties to commit the UK…

    Read more

  • News releases

    LifeArc funds pivotal clinical trial to treat an ultra-rare genetic disease with possible link to leader of the mutiny on the Bounty in 1789

    A pivotal clinical trial to look at repurposing the UK-licensed medicine, deferiprone, for patients with neuroferritinopathy, an ultra-rare genetic disease…

    Read more

  • News releases

    ReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and Kenya

    ReAct (Action on Antibiotic Resistance) Africa, in partnership with self-funded medical research organisation and charity LifeArc, is excited to introduce…

    Read more

  • Black background with text: Announcing team PROTECT as one of five new global Cancer Grand Challenges teams. PROTECT will be awarded up to $25m over five years to tkae on the Solid tumours in children challenges. Logo of Cancer Grand Challenges and Cancer Research UK and National Cancer Institute in top right corner.
    News releases

    LifeArc joins £20m international project to develop novel cancer treatment for children

    LifeArc is investing up to £4.9 million to bolster a joint international project to create new cancer therapies specifically for…

    Read more

  • A scientist in a white lab coat pipettes liquid into a small vial.
    Articles & blogs

    6 challenges in rare disease research and how we can overcome them

    Rare conditions, individually, have low patient numbers. However, with more than 7,000 rare diseases identified, collectively there are millions of…

    Read more

  • News releases

    LifeArc’s Edinburgh labs featured in STV segment about innovations for people living with bronchiectasis

    Recently, our team had the pleasure of hosting STV for an exciting feature at the BioQuarter campus in Edinburgh. Watch…

    Read more

WordPress development by Andy White using PorterWP